今年6月7日,渤健(Biogen)基于β-淀粉样蛋白假说而开发的第一款用于治疗AD的单克隆抗体药物Aduhelm历经波折,终获得美国FDA批准上市,是近20年来AD领域首款新疗法...查看全文
$Trident(TDAC)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2019-10-15 AccNo: 0000912282-19-000122 Size: 84 KB 网页链接
$Trident(TDAC)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2019-10-15 AccNo: 0000912282-19-000124 Size: 84 KB 网页链接
$Trident(TDAC)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2019-08-14 AccNo: 0001213900-19-015802 Size: 1 MB 网页链接
$Trident(TDAC)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2019-05-15 AccNo: 0001615774-19-007925 Size: 1 MB 网页链接
$Trident(TDAC)$ 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] Filed: 2019-03-27 AccNo: 0001615774-19-004584 Size: 2 MB 网页链接
$Trident(TDAC)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2019-02-14 AccNo: 0001076809-19-000012 Size: 59 KB 网页链接
$Trident(TDAC)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2019-02-14 AccNo: 0001493152-19-002015 Size: 123 KB 网页链接
$Trident(TDAC)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2019-02-14 AccNo: 0001357550-19-000033 Size: 108 KB 网页链接
$Trident(TDAC)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2019-02-13 AccNo: 0001615774-19-002365 Size: 70 KB 网页链接
$Trident(TDAC)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2019-02-12 AccNo: 0000904454-19-000207 Size: 80 KB 网页链接